ODDB.org: Open Drug Database

Home - 67774 - 01 - 003

Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone, Crème - 60 g

Swissmedic Key	67774003	Registration Holder	Bailleul (Suisse) SA
Name	Dermafusone 20 mg/g acide fusidique et 1 mg/g béthaméthasone, Crème	Date of registration	13.04.2021
		Introduction of Sequence	13.04.2021
ATC-Classification	Betamethasone and Antibiotics (D07CC01)	Revision date
WHO	WHO-DDD	Valid until	12.04.2026
Index Therapeuticus (BSV)	10.05.20.	Show package size	60 g
Index Therapeuticus (Swissmedic)	10.05.20.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680677740039	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

acidum fusidicum 20 mg, betamethasonum 1 mg ut betamethasoni valeras alcohol cetylicus et stearylicus 72 mg, macrogoli aether cetostearylicus, chlorocresolum 1 mg, natrii dihydrogenophosphas dihydricus, paraffinum liquidum, vaselinum album, int-rac-alpha-tocopherolum, natrii hydroxidum, aqua purificata, q.s. ad unguentum pro 1 g.

Packungsbestandteile

Galenic Form

Cream

Excipiens

Active Agent	Dose
Fusidic Acid	20 mg
Betamethasone	1 mg

BAG: Active Agent	Dose
Fusidic Acid	20 mg
Betamethasone	1 mg

Inactive agents	Dose
Aqua Purificata
Chlorocresolum	1 mg
Int-Rac-Alpha-Tocopherolum
Macrogoli Aether Cetostearylicus
Sodium Dihydrogenophosphate Dihydrate
Sodium Hydroxide
Paraffine Liquide
Stearylicus	72 mg
Vaselinum Album

Source

Data was imported : 06.08.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH